Compare Marathon Petroleum Corp (MPC) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Petroleum Corp vs Sana Biotechnology Inc — how do they compare? Marathon Petroleum Corp trades at $334 (market cap $94.48B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Marathon Petroleum Corp is far larger — about 83.6× Sana Biotechnology Inc's market cap, and Marathon Petroleum Corp pays a 1.19% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| MPC | SANA | |
|---|---|---|
Market Cap | $94.48B | $1.13B |
Sector | Energy | Health |
52-Week High | $336.42 | $5.92 |
52-Week Low | $159.11 | $2.68 |
Enterprise Value | $121.00B | $1.05B |
Dividend Yield | 1.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marathon Petroleum (MPC) trades at $320.32, up 7.42% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat expectations by 22.1%. The stock is in a bullish technical trend, supported by robust refining margins and disciplined operations. Recent news highlights MPC's advantage from global refining tightness and geopolitical disruptions. Valuation ratios like P/E of 11.67 and P/S of 0.65 suggest potential undervaluation relative to earnings growth.
Outlook remains positive with analyst consensus at Buy (75.76%) and a $332.70 price target, though risks include volatile energy markets and debt levels. Earnings growth and cash returns via dividends and buybacks are key catalysts, but investors should monitor refining margin sustainability and macroeconomic pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
